Literature DB >> 28887333

Rapid estrogen receptor-α signaling mediated by ERK activation regulates vascular tone in male and ovary-intact female mice.

Seong Chul Kim1, Austin C Boese1, Matthew H Moore1, Rea M Cleland1, Lin Chang2, Patrice Delafontaine3, Ke-Jie Yin4, Jean-Pyo Lee5,6, Milton H Hamblin1.   

Abstract

Estrogen has been shown to affect vascular reactivity. Here, we assessed the estrogen receptor-α (ERα) dependency of estrogenic effects on vasorelaxation via a rapid nongenomic pathway in both male and ovary-intact female mice. We compared the effect of a primary estrogen, 17β-estradiol (E2) or 4,4',4″-(4-propyl-[1H]pyrazole-1,3,5-triyl)tris-phenol (PPT; selective ERα agonist). We found that E2 and PPT induced greater aortic relaxation in female mice than in male mice, indicating ERα mediation, which was further validated by using ERα antagonism. Treatment with 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride (MPP dihydrochloride; ERα antagonist) attenuated PPT-mediated vessel relaxation in both sexes. ERα-mediated vessel relaxation was further validated by the absence of significant PPT-mediated relaxation in aortas isolated from ERα knockout mice. Treatment with a specific ERK inhibitor, PD-98059, reduced E2-induced vessel relaxation in both sexes but to a lesser extent in female mice. Furthermore, PD-98059 prevented PPT-induced vessel relaxation in both sexes. Both E2 and PPT treatment activated ERK as early as 5-10 min, which was attenuated by PD-98059 in aortic tissue, cultured primary vascular smooth muscle cells (VSMCs), and endothelial cells (ECs). Aortic rings denuded of endothelium showed no differences in vessel relaxation after E2 or PPT treatment, implicating a role of ECs in the observed sex differences. Here, our results are unique to show estrogen-stimulated rapid ERα signaling mediated by ERK activation in aortic tissue, as well as VSMCs and ECs in vitro, in regulating vascular function by using side-by-side comparisons in male and ovary-intact female mice in response to E2 or PPT. NEW & NOTEWORTHY Here, we assessed the estrogen receptor-α dependency of estrogenic effects in vasorelaxation of both male and ovary-intact female mice by performing side-by-side comparisons. Also, we describe the connection between estrogen-stimulated rapid estrogen receptor-α signaling and downstream ERK activation in regulating vascular function in male and ovary-intact female mice.

Entities:  

Keywords:  endothelial cells; estrogen; estrogen receptor-α; extracellular signal-regulated kinase; vascular function

Mesh:

Substances:

Year:  2017        PMID: 28887333      PMCID: PMC5867661          DOI: 10.1152/ajpheart.00841.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  53 in total

1.  Sex-specific acute effect of estrogen on endothelium-derived contracting factor in the renal artery of hypertensive Dahl rats.

Authors:  Ling Zhang; Hiroaki Kosaka
Journal:  J Hypertens       Date:  2002-02       Impact factor: 4.844

2.  Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice.

Authors:  R H Karas; J B Hodgin; M Kwoun; J H Krege; M Aronovitz; W Mackey; J A Gustafsson; K S Korach; O Smithies; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury.

Authors:  Gary Pare; Andrée Krust; Richard H Karas; Sonia Dupont; Mark Aronovitz; Pierre Chambon; Michael E Mendelsohn
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

4.  Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta.

Authors:  Xiaomei Guo; Mahnaz Razandi; Ali Pedram; Ghassan Kassab; Ellis R Levin
Journal:  J Biol Chem       Date:  2005-03-11       Impact factor: 5.157

5.  Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.

Authors:  Yan Zhu; Zhao Bian; Ping Lu; Richard H Karas; Lin Bao; Daniel Cox; Jeffrey Hodgin; Philip W Shaul; Peter Thoren; Oliver Smithies; Jan-Ake Gustafsson; Michael E Mendelsohn
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

6.  Nuclear import mechanism for myocardin family members and their correlation with vascular smooth muscle cell phenotype.

Authors:  Seiji Nakamura; Ken'ichiro Hayashi; Kazuhiro Iwasaki; Tomoaki Fujioka; Hiroshi Egusa; Hirofumi Yatani; Kenji Sobue
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

7.  Human vascular smooth muscle cells contain functional estrogen receptor.

Authors:  R H Karas; B L Patterson; M E Mendelsohn
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

8.  Free diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculations.

Authors:  Idit Oren; Sarel J Fleishman; Amit Kessel; Nir Ben-Tal
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

9.  Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis.

Authors:  Denny L Cottle; Gloria M A Ursino; Sally Chi Ieng Ip; Lynelle K Jones; Tia Ditommaso; Douglas F Hacking; Niamh E Mangan; Natalie A Mellett; Katya J Henley; Dmitri Sviridov; Claudia A Nold-Petry; Marcel F Nold; Peter J Meikle; Benjamin T Kile; Ian M Smyth
Journal:  Hum Mol Genet       Date:  2014-09-10       Impact factor: 6.150

10.  Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling.

Authors:  Sarah H Lindsey; Liu Liu; Mark C Chappell
Journal:  Steroids       Date:  2013-11-16       Impact factor: 2.668

View more
  4 in total

1.  17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.

Authors:  Justin C Wheeler; Simone Vanoni; Chang Zeng; Lisa Waggoner; Yanfen Yang; David Wu; Jazib Uddin; Rebekah Karns; Leah Kottyan; Vincent Mukkada; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-12-20       Impact factor: 10.793

2.  Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Franck Mauvais-Jarvis; Sarah H Lindsey
Journal:  Menopause       Date:  2019-02       Impact factor: 2.953

Review 3.  ERK1/2-RSK2 Signaling in Regulation of ERα-Mediated Responses.

Authors:  Deborah A Lannigan
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

4.  Estradiol replacement therapy regulates innate immune response in ovariectomized arthritic mice.

Authors:  Ayda Henriques Schneider; Alexandre Kanashiro; Sabrina Graziani Veloso Dutra; Raquel do Nascimento de Souza; Flávio Protásio Veras; Fernando de Queiroz Cunha; Luis Ulloa; André Souza Mecawi; Luis Carlos Reis; David do Carmo Malvar
Journal:  Int Immunopharmacol       Date:  2019-05-02       Impact factor: 4.932

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.